| Further US$6 million from Unsecured Bridging Finance Facility | |
| | |
|
EMED Mining Public Limited, the Europe-based minerals development and exploration company, is pleased to announce that following the announcement on 30 March 2015, the Company has now received the further US$6 million (prior to deduction of fees and expenses) available under the unsecured bridging finance facility with Trafigura Beheer BV ("Trafigura"), Orion Mine Finance (Master) Fund I LP ("Orion") and Hong Kong Xiangguang International Holdings Limited ("Hong Kong Xiangguang"), an affiliate of Yanggu Xiangguang Copper Co. Limited ("XGC") (the "Loan"). Following receipt of the above funds, the total amount drawn down from the Loan is US$30 million.
Alberto Lavandeira, CEO of the Company, commented: "We continue to work with all parties and this further show of support from our cornerstone investors is very pleasing. We remain committed to finalising our definitive documentation on the long term funding arrangements as we keep on track for the reopening of Proyecto Riotinto."
Enquiries:
EMED Mining Roger Davey/Alberto Lavandeira +34 959 59 28 50
Canaccord Genuity Limited Ryan Gaffney/Henry Fitzgerald-O'Connor +44 207 523 8000
Brandon Hill Capital Oliver Stansfield +44 203 463 5061
Walbrook PR Nick Rome +44 207 933 8783
For further information on the Company's activities, visit www.emed-mining.com.
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
CODE : EMED.L |
ISIN : CY0000100319 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |